BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Patent News
Mesoblast Limited (MSB.AX) Key Patent Allowed In Japan For The Treatment Of Heart Diseases, Stroke, And Other Vascular Conditions 3/27/2015
OXIS International, Inc. (OXIS) Biotech Executes Option Agreement To Certain Patents/Intellectual Properties Owned By The University of Pittsburgh 3/26/2015
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Israeli Patent Acceptance Notice For The Use Of TB4 To Prevent Tissue Damage Associated With Heart Attack And Stroke Treatments 3/26/2015
Moberg Pharma AB (Formerly known as Moberg Derma) Announces Grant Of EU Patent For MOB-015 Related To Topical Treatment Of Onychomycosis (Nail Fungus) 3/26/2015
Acasti Pharma Granted Composition & Use Patent In China 3/25/2015
Moberg Pharma AB (Formerly known as Moberg Derma) Announces Issue Of U.S. Patent For Kerasal Nail 3/25/2015
Enzymotec Reports A Decision Of The U.S. Patent And Trademark Office 3/24/2015
Sunshine Biopharma, Inc. Announces Issuance Of Notice Of Allowance For The Patent Application Covering Adva-27a Anticancer Compound In India 3/24/2015
Suven Life Sciences Ltd Secures Three (3) Product Patents For Their NCEs In Canada, Japan And Korea 3/24/2015
ISA Pharmaceuticals Granted European Patent For The Intradermal Administration Of ISA101 3/24/2015
Highland Therapeutics Announces Receipt Of Two Notices Of Allowance For Patents On Lead Product 3/24/2015
BeyondSpring Extends Plinabulin IP Portfolio With Two New Method of Treatment Patent Applications 3/23/2015
Onxeo Consolidates Its Intellectual Property With The Grant Of New Patent Protection Of Validive In Japan Until 2029 3/18/2015
Key TxCell Patent To Be Granted In The United States For Its Lead Product Ovasave 3/18/2015
Daxor Corporation (DXR) Receives Notification Of Patent Approval And Issues An Update On Its Stock Buyback Program 3/17/2015
InSite Vision (ISV) Announces Settlement Of Patent Infringement Lawsuit Against Mylan Pharmaceuticals, Inc. (MYL) 3/17/2015
Suven Life Sciences Ltd Secures 2 (Two) Product Patents For Their NCE’s Through New Mechanism Of Action - H3 Inverse Agonist In USA & New Zealand 3/16/2015
Auris Medical AG (EARS) Announces Recently Granted Patent In India For The Treatment Of Tinnitus 3/13/2015
Enzymotec Granted New Patents In The United States And Australia Relevant To Phospholipid-Based Products 3/13/2015
Provectus Biopharmaceuticals Inc. Awarded PH-10 Patent By U.S. Patent And Trademark Office 3/12/2015
Federal Court Rules Millennium Health Infringes Patent Exclusively Licensed To Ameritox, Ltd. 3/12/2015
FLAG Therapeutics Announces Bi-specific FTAC Patent Issuance 3/11/2015
Highland Therapeutics Announces Notice Of Patent Allowance; Provides Update On Amphetamine Development Plans 3/10/2015
Suven Life Sciences Ltd Secures One (1) Product Patent Each In Eurasia And Israel 3/9/2015
Stevia Corp. Files Provisional Patent With The United States Patent And Trademark Office For A Non-Invasive And Simple To Use Delivery System For Cannabinoids 3/9/2015
Actavis (ACT) Confirms District Court Ruling In Atelvia Patent Litigation 3/5/2015
Islet Sciences Confirms Issuance Of U.S. Patent For Using SGLT2 Inhibitors To Treat NASH/NAFLD 3/5/2015
European Patent To Strengthen MediGene AG (MDGEF.PK)'s Dendritic Cell (DC) Vaccines Program 3/5/2015
Jaguar Animal Health Files Two Provisional Patent Applications, Deepening Its Pipeline Of Proprietary Gastrointestinal Products For Animals 3/4/2015
Cleveland Biolabs Inc. (CBLI) And Incuron Announce Growth Of Curaxin CBL0137 Patent Portfolio With U.S. Composition Of Matter Patent 3/3/2015
Regen BioPharma Files Patent Application For Treatment Of Myelodysplastic Syndrome Utilizing Gene Silencing Therapy 3/3/2015
VG Life Sciences, Inc. (VGLS) Granted Key Composition Of Matter Patent 3/2/2015
Merus Labs International Inc. Announces Settlement Of Canadian Patent Litigation 3/2/2015
CSIRO Maintains Foundational Patent For RNAi Gene Silencing Technology After European Opposition 3/2/2015
DelMar Pharmaceuticals Receives Notice Of Allowance Of Fourth U.S. Patent Covering Methods Of Use And Compositions For VAL-083 3/2/2015
University of Maryland Release: Patent Awarded For Compounds That Inhibit Formation And Persistence Of Biofilms 3/2/2015
FLAG Therapeutics Announces The Issuance Of A New U.S. Patent That Includes Composition Of Matter On Their Bi-Specific Lead Candidate For Oncology 2/27/2015
Collegium Pharmaceutical, Inc. Announces Notice Of Allowance For U.S. Patent Covering Deterx, An Abuse-Deterrent, Extended-Release, Technology Platform 2/26/2015
Meditope Biosciences Announces Issuance Of Additional Patent For SnAP Technology 2/25/2015
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Israeli Patent For Treating And Repairing Heart Damage 2/25/2015
Ocata Therapeutics Receives Two New Patents For Immune-Modulatory Cell Technology 2/25/2015
Actavis (ACT) Confirms Generic Uceris Patent Challenge 2/25/2015
XstalBio: US Patent Issued For Stabilization Of Therapeutic Proteins 2/25/2015
iBio, Inc. (IBIO) Adds Anthrax Antibodies To Product Pipeline 2/25/2015
BioBlast Pharma (ORPN) Receives Notice Of Allowance From USPTO Covering Cabaletta For The Treatment Of OPMD 2/24/2015
BeyondSpring Files Composition Of Matter Patent Application For Plinabulin Combination Therapy In Immuno-Oncology 2/24/2015
Ciclofilin Pharmaceuticals Granted Patent In Japan For Cyclophilin Inhibitor Drugs 2/24/2015
Opsona Therapeutics Ltd. Patent Issued In USA Covering An Antibody Directed Against Toll-Like Receptor-2 (TLR-2) And The Use And Development Thereof 2/23/2015
Opsona Therapeutics Ltd. Patent Issued In US And EU Covering The Opsona-Developed Antibody OPN-305, Which Is Directed Against Toll-Like Receptor-2 (TLR-2) And The Use And Development Thereof 2/20/2015
Aegis Therapeutics, LLC Awarded U.S. Patent No. 8,927,497 For Non-Invasive Delivery Of Anti-Seizure Drugs 2/18/2015
Synageva BioPharma (GEVA) European Patent Issued For Treatment Of LAL Deficiency 2/18/2015
Can-Fite BioPharma (CFBI) Receives Notice Of Allowance In U.S. For Psoriasis Patent 2/17/2015
AdvaStim Expands Intellectual Property Portfolio With New Neurostimulation Patent 2/17/2015
Orexo AB (ORXOF) Broadens ZUBSOLV Product Range and Announces Newly Listed Granted U.S. Patent 2/17/2015
Rosetta Genomics Ltd. (ROSG) Announces Key Patent Allowances In U.S. And Europe 2/17/2015
Suven Life Sciences Ltd Secures 4 (Four) Product Patents For Their NCE’s Through New Mechanism Of Action – H3 Inverse Agonist In Australia, Canada, Japan And New Zealand 2/16/2015
AtheroNova Inc. (AHRO.OB) Receives Notice Of Issuance Of Its 3rd US Patent 2/13/2015
Kinex Pharmaceuticals Licenses Patents From Hong Kong Polytechnic University 2/13/2015
Hedge Fund Manager Picks Acorda Therapeutics (ACOR) as His First Victim Against the Pharmaceutical Industry and Its "BS" Patents 2/12/2015
RainDance Technologies Announces Patent Infringement Lawsuit Against 10X Genomics 2/12/2015
New Reverdia Patents Strengthen Biosuccinium™ Licensing 2/12/2015
iBio, Inc. (IBIO) Receives U.S. And European Patents For Protein Expression Technology 2/12/2015
AmnioLife Files Collagen Membrane Preservation Patent 2/11/2015
Novogen Limited (NVGN) Lodges Key Super-benzopyran Patent 2/11/2015
Moberg Pharma AB (Formerly known as Moberg Derma) Announces Issue Of U.S. Patent Related To MOB-015 For The Treatment Of Onychomycosis 2/11/2015
Cleveland Biolabs Inc. (CBLI) Announces Expansion of Entolimod Patent Portfolio With New Composition of Matter Patents 2/11/2015
Cara Therapeutics, Inc. (CARA) Issued Additional U.S. Patent Covering The Expanded Use Of Kappa Opioid Receptor Agonist CR845 And Analogs For The Treatment And Prevention Of Pain-Related Conditions 2/10/2015
Drawbridge Pharmaceuticals Granted Notice Of Allowance For Divisional Patent In The United States 2/10/2015
Pivotal Therapeutics Inc. Announces The Issuance Of Two Patents Both Related To The Combination Of VASCAZEN® With Key Cholesterol Lowering Agents (Statins) And Cholesterol Absorption Inhibitors 2/10/2015
BrainStorm Cell Therapeutics Inc. Receives Notice Of Allowance For Its Nurown Technology Platform From Israel's Patent Office 2/9/2015
MicroBiome Therapeutics LLC Receives Notice Of Allowance For U.S. Patent Covering Glyceollin As A Treatment For Diabetes And Obesity 2/9/2015
Mylan Inc. (MYL) Confirms First-to-File Patent Challenge Relating To NEXAVAR 2/9/2015
VBL Therapeutics (VBLX) Receives European Patent Issuance On Lecinoxoid Platform Technology 2/6/2015
Creative Medical Health Files Patent On Multiple Sclerosis Stem Cell Therapy 2/6/2015
NeuroNascent, Inc. Announces Expanded Patent Coverage In US And Russia For Its Alzheimer's Disease And Down Syndrome Therapeutics 2/5/2015
Horizon Pharma plc.  (HZNP) Announces Issuance Of VIMOVO® Related Patent With Protection To 2031 From United States Patent And Trademark Office 2/5/2015
ContraVir Pharmaceuticals' HBV Compound CMX157 Receives Extended Patent Life 2/4/2015
iBio, Inc. (IBIO) Adds To iBioModulator Portfolio And Product Pipeline 2/4/2015
MediciNova, Inc. Receives Notice Of Allowance For New Patent Covering MN-001 And MN-002 For The Treatment Of NASH 2/4/2015
Aurinia (ISA.TO) Announces Recently Granted Nanomicellar Formulation Patents In Japan And China For Topical Ophthalmic Administration Of Voclosporin 2/4/2015
Oxis Biotech Inc. Provides Update For P62-ZZ Multiple Myeloma Patent Application 2/4/2015
ProLynx Issued Key Patent For Using Releasable Linkers On Insoluble Carriers 2/4/2015
ARCA biopharma Announces Patent Issuance For Methods And Compositions Of S-Isomer Formulation Of Gencaro 2/4/2015
Enzymotec Announces Favorable Response From The Australian Patent Office 2/3/2015
RXi Pharmaceuticals (RXII) Strengthens Intellectual Property Portfolio For Ocular Indications 2/3/2015
EastGate Biotech Provides Update On Its Patent Portfolio 2/3/2015
MMRGlobal Biotech Assets In Play As Company Is Awarded Second U.S. Cancer Fighting Patent 2/2/2015
MediciNova, Inc. Receives New Patent Covering MN-029 (denibulin) di-hydrochloride In Japan 1/30/2015
VG Life Sciences, Inc. (VGLS) Announces Issuance Of Patent Covering Treatment Of Inflammatory Bowel Disease With Clip-Inducing Agent 1/29/2015
Apricus Biosciences (APRI) Announces Issuance Of U.S. Patent For Rayva™ 1/28/2015
Adamis Pharmaceuticals (ADMP) Receives Notice Of Allowance For U.S. And Japanese Patents For Its Dry Powder Inhaler 1/28/2015
Garnet Biotherapeutics, Inc. Files Amicus Brief To Support Its Victory Against Athersys, Inc. (ATHX) In Patent Interference 1/28/2015
BioTime (BTX) Announces Issuance Of 14 New Patents In The Fields Of Regenerative Medicine, Stem Cell Technology, And Cancer Therapy 1/26/2015
Provectus Biopharmaceuticals Inc.’ Novel Synthesis Patent Application Allowed By Chinese Patent Office 1/26/2015
KannaLife Sciences, Inc. Files PCT Patent Application For Novel Treatments for Neurodegenerative Disorders 1/23/2015
European Patent Office Issues Key Patent To TiGenix For Expanded Adipose-Derived Stem Cell Compositions 1/22/2015
Supernus Pharmaceuticals (SUPN) Sues TWi Pharmaceuticals, Inc. For Infringement Of Oxtellar XR® Patents 1/22/2015
Ablynx (ABLYF) Successfully Opposes Patent Appeal Case By Domantis Limited (GlaxoSmithKline (GSK)) 1/22/2015
Fuisz Pharma Announces New Patent Allowance For Its Helicopter™ Tablet Shape With Improved Swallowability; Adds To Existing Tablet Shape Patent Estate 1/20/2015
Mylan Inc. (MYL) Release: U.S. Supreme Court Partially Modifies Standard Of Review Of Patent Claim Construction And Remands Review Of Teva's '808 Patent On Copaxone® To Federal Circuit Court Of Appeals 1/20/2015
Suven Life Sciences Ltd Secures One (1) Product Patent Each In Australia & Hong Kong, Two (2) Product Patents From Japan 1/20/2015
Supernus Pharmaceuticals (SUPN) Sues Par Pharmaceutical Companies, Inc. (PRX) For Infringement Of Trokendi XR® Patents 1/19/2015
Akorn, Inc. (AKN) Confirms Generic Durezol® Patent Challenge 1/16/2015
Vanda Pharmaceuticals, Inc. (VNDA) Announces Listing of a New Fanapt® Patent In The FDA Orange Book 1/16/2015
Oramed Pharmaceuticals Inc. (ORMP) Granted Patent In Israel For Oral Administration Of GLP-1 1/16/2015
Spotlight Innovation Subsidiary Celtic Biotech Iowa Granted Patent By The U.S. Patent And Trademark Office 1/16/2015
3SBio Inc. (SSRX) Signs Exclusive Patent License Agreement For DIG-KT, A Bi-Specific mAb Targeting VEGFR2 And Tie-2 With Pharmabcine 1/15/2015
Gilead (GILD)'s India Patent Roadblock May Spur More Sovaldi Copies 1/15/2015
DelMar Pharmaceuticals Receives Notice Of Allowance For Third US Patent For VAL-083 1/13/2015
NanoSphere Health Sciences Announces Patent-Pending Status For Nanoparticle Encapsulation Of NSAIDs 1/13/2015
OncoSec Medical Inc. Obtains Allowance Of Key Patent Application For Intratumoral Delivery Of Plasmid IL-15 1/13/2015
BioD Receives U.S. Patent For Unique Placental Tissue Technology 1/12/2015
Aradigm Corporation (ARDM) Granted Key Composition Of Matter Patents For Pulmaquin In Europe And Australia 1/12/2015
Silver Bullet Therapeutics Announces Issuance Of U.S. Patent No. 8,927,004 For Bioabsorbable Substrates That Controllably Release Metal Ions 1/12/2015
Chimerix, Inc. (CMRX) Receives Notice Of Allowance For Brincidofovir Composition Of Matter Patent Extending Exclusivity To 2034 1/12/2015
Altos Therapeutics Receives Second Issued Patent Covering Novel Dopamine D2/D3 Antagonists For The Treatment Of Gastrointestinal Diseases 1/12/2015
Oxis Biotech Executes Worldwide Exclusive Patent Licensing "P62 Chemical Agents And Multiple Myeloma Therapeutics" With Dr. Xiang-Qun (Sean) Xie, Professor Of Pharmaceutical Sciences At University of Pittsburgh 1/12/2015
Helsinn Healthcare SA Reaches Settlement Agreement Regarding Patent Dispute On ALOXI® 1/12/2015
Dicerna Pharmaceuticals (DRNA) Announces Issuance Of US Patent Providing Broad Coverage Of DsiRNA-EX RNAi Payloads 1/12/2015
SciFluor Life Sciences, LLC Awarded U.S. Patent For KCNQ2/3 Activator Designed For Treatment Of Epilepsy And Related Neurological Disorders 1/8/2015
Pluristem Therapeutics (PSTI) Granted Patent For Foundational Cell Harvesting Technology In South Africa 1/6/2015
Biomatrica Announces Patent Award For Novel Method Of Stabilizing And Storing Biological Materials To Improve Downstream Testing 1/6/2015
Cellectis (ALCLS) Announces The Issuance By The USPTO Of A Patent Covering A Seminal Nuclease-Based “Gene Editing” Method 1/6/2015
RestorGenex Announces Issuance Of European Patent For Its Dermatology Program 1/5/2015
Alzheon Announces Patent Allowance In Europe For ALZ-801 In Development For Alzheimer’s Disease 1/5/2015
Suven Life Sciences Ltd Secures Three (3) Product Patents In Eurasia, Japan, And Mexico 12/30/2014
Repros Therapeutics Inc. (RPRX) Confirmed As Sole Owner 12/29/2014
Nuvo Research Inc. (NRI.TO) Granted Additional U.S. Patent For Treatment Of Allergic Rhinitis With WF10 12/22/2014
TWi Biotech Receives Notice Of Patent Allowance For Its Lead Drug Candidate AC-201 For The Indication Of Type II Diabetes In China 12/22/2014
Prima Biomed (PRR.AX) Announces Immutep S.A.'s IMP321 Patent Application Receives Canadian Patent Office Notice Of Grant 12/22/2014
Harbour Antibodies Announces First U.S. Patent For Novel Transgenic Mouse Antibody Technology For Next Generation Therapeutic Antibody Discovery 12/19/2014
Anergis Granted U.S. Patent For Ragweed Allergy Vaccine AllerR 12/19/2014
Regeneus (RGS.AX) (ASX:RGS) Patent Granted For Protecting Cryopreserved Stem Cells 12/19/2014
Sienna Labs Obtains Sixth Patent Relating To Use Of Plasmonic Nanoparticles In Treatment Of Sebaceous Glands And Hair 12/19/2014
Celator Pharmaceuticals, Inc. Receives European Patent Allowance On Nanoparticle Delivery Technology 12/18/2014
Pronutria Biosciences Announces Issuance Of Key Patents From USPTO On Compositions And Methods Relating To Oral Biologics 12/18/2014
BioBlast Pharma (ORPN) Receives Notice Of Patent Issuance From USPTO For Its Novel Fusion Protein-Based Platform For The Treatment Of Friedrich's Ataxia 12/17/2014
ImmunoCellular Therapeutics, Ltd (IMUC) Announces Issuance Of Key Patent For ICT-107 Cancer Vaccine 12/17/2014
Elite Pharmaceuticals, Inc. (ELI) Awarded Second Canadian Patent For Abuse Deterrent Drug Formulation 12/16/2014
United States Patent Office Grants Apnea Sciences Patent 12/16/2014
SomaGenics Inc. Awarded Four Patents Spanning Its miRNA And RNAi Programs 12/16/2014
TherapeuticsMD, Inc.  (TXMD) Receives Five New Patent Allowances, Further Strengthens IP Assets 12/16/2014
Biocept, Inc. (BIOC) Expands Worldwide Microchannel Patent Protection To South Korea 12/15/2014
Heptares Extends Global Patent Protection For GPCR-Focused Drug Discovery Platform With Grant Of Core Patents In The United States 12/15/2014
Wilshire Confirms First-to-File Patent Challenge Relating To LASTACAFT 12/12/2014
Suven Life Sciences Ltd Secures (5) Product Patents For Their Nces In Israel, Japan, China And New Zealand 12/12/2014
MediciNova, Inc. Receives Notice Of Allowance For New Patent Covering MN-001 And MN-002 For The Treatment Of Liver Disorders 12/10/2014
MultiCell Technologies Inc. (MCET.OB) Files Novel Antibody-Drug Conjugate Patent Application 12/10/2014
Nordic Nanovector Patent Granted In Japan 12/10/2014
NeuroMetrix, Inc. (NURO) Expands Intellectual Property For Wearable Pain Relief Technology 12/10/2014
Novadaq Technologies, Inc. Granted Additional SPY Technology Patent Protection In The U.S. 12/9/2014
Cubist Pharmaceuticals, Inc. (CBST) Comments On CUBICIN Patent Litigation 12/9/2014
KemPharm, Inc. Receives Notice Of Allowance For NME Prodrug Of Methylphenidate, KP415 12/5/2014
SciFluor Life Sciences, LLC Awarded U.S. Patent For Integrin avß3 Inhibitors Designed For The Topical Treatment Of Retinal Disease 12/4/2014
Adamas Pharmaceuticals (ADMS) Issued Six Additional U.S. Patents 12/4/2014
Keryx Biopharmaceuticals (KERX) Announces Issuance Of A New U.S. Patent For Auryxia (Ferric Citrate) Covering Orally Administrable Forms 12/4/2014
THERAVECTYS Further Strengthens The Intellectual Property Of Its Lentiviral Vector Technology 12/3/2014
Sienna Labs Obtains Fifth Patent Relating To Use Of Plasmonic Nanoparticles In Treatment Of Sebaceous Glands And Hair 12/3/2014
Milo Biotechnology Announces Patent Issuance 12/3/2014
GlySure Strengthens Intellectual Property Portfolio With Three New Patents 12/3/2014
Galena Biopharma  (GALE) Receives Notice Of Allowance Of U.S. Patent Application For GALE-401 (Anagrelide Controlled Release) Composition Of Matter 12/2/2014
IntelGenx Corp. Announces Update To Settlement Of U.S. Patent Litigation Related To Forfivo XL 11/26/2014
Mylan Inc. (MYL) Confirms First-To-File Patent Challenge Relating To BREVIBLOC 11/25/2014
Xenetic Biosciences Provides Update On Substantial Patent Grants And Allowances In U.S. and Worldwide 11/25/2014
Supernus Pharmaceuticals (SUPN) Files Lawsuit Against Zydus Pharmaceuticals (USA) Inc. In U.S. Court For Infringement Of Patents Covering Its Antiepileptic Drug, Trokendi XR 11/25/2014
Regen BioPharma Acquires University of Toronto Cancer Stem Cell Intellectual Property 11/25/2014
Arena Pharmaceuticals, Inc. (ARNA) Issued Composition Of Matter Patent By United States Patent And Trademark Office For Ralinepag And Related Compounds 11/25/2014
IntelGenx Corp. Announces Settlement Of U.S. Patent Litigation Related To Forfivo XL 11/25/2014
ChromaDex, Inc. Announces Two Patent Issuances For Novel Ingredient, Pterostilbene 11/24/2014
Forward Pharma (FWP) Receives Issue Notification For Erosion Matrix Patent In The U.S. 11/24/2014
Supernus Pharmaceuticals (SUPN) Announces Issuance Of Fifth U.S. Patent Protecting Trokendi XR(R) 11/24/2014
Catalyst Pharmaceuticals (CPRX) Announces Notice Of Allowance Of U.S. Patent Application For The Reduction Or Elimination Of Visual Field Defects By Treating Patients With CPP-115 11/24/2014
Ebola Vaccine Running Into Patent Cover In Canada? 11/21/2014
Orexigen Therapeutics, Inc. (OREX) Announces Allowance Of New U.S. Patent For Contrave (Naltrexone Hcl / Bupropion Hcl Extended Release) 11/21/2014
Highland Therapeutics Receives Second Notice Of Allowance For Patent On Lead Product 11/20/2014
Seegene, Inc. Receives US Patent For TOCE Technology 11/19/2014
Aphios Granted United States Patent For Nanotechnology Co-Encapsulation Of Combination Drugs & Drug Products 11/18/2014
3SBio Inc. (SSRX) Signs Exclusive Patent License Agreement For Tanibirumab, An Anti-VEGFR2/KDR Mab With Pharmabcine 11/18/2014
OXiGENE (OXGN) Announces Issuance Of European Patent for OXi4503 In Acute Myeloid Leukemia And Other Myeloid Malignancies 11/17/2014
Regeneus (RGS.AX) Acne Treatment Patent Granted 11/14/2014
AbbVie (ABBV) Uses Patents To Ambush Gilead (GILD) 11/14/2014
Foamix Pharmaceuticals, Ltd. (FOMX) Announces Two New U.S. Patents Relating To Topical Tetracycline Compositions 11/13/2014
Highland Therapeutics Receives Notice Of Allowance For Patent On Lead Product 11/13/2014
BioLargo, Inc. (BLGO.PK) Issued Patent For Its Platform Of Liquid And Hydrogel Iodine Technologies 11/13/2014
Pluristem Therapeutics (PSTI) Granted Patents In Australia And New Zealand For Use Of Placental Cells In The Treatment Of Multiple Indications 11/12/2014
New U.S. Patent Issued To Dyadic International, Inc. 11/12/2014
Aegis Therapeutics, LLC Awarded Patent For Intranasal Administration Of Active Agents To The Central Nervous System 11/12/2014
Horizon Pharma plc.  (HZNP) Announces Favorable Markman Ruling in RAYOS® (prednisone) Delayed-Release Tablets Patent Infringement Litigation 11/12/2014
Genovis Sues U.S. Company For Patent Infringement 11/11/2014
Matinas BioPharma Receives Notice Of Allowance Of U.S. Patent For MAT9001 11/10/2014
Supernus Pharmaceuticals (SUPN) Announces Issuance Of Fourth U.S. Patent Protecting Trokendi XR® 11/7/2014
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Receives U.S. Patent Claiming Alternative Methods to Manufacture Pancreatic Progenitor Cells In Vitro 11/6/2014
PuriCore Granted Two U.S. Patents 11/5/2014
Reflect Scientific, Inc. Files Patent For Low Temperature Freezer Technology 11/4/2014
OncoMed Pharmaceuticals, Inc. (OMED) Granted Anti-DLL4/Anti-VEGF Bispecific Antibody Patent In The U.S. 11/3/2014
U.S. Patent Office Significantly Extends The Term Of Three RegenRx Patents 11/3/2014
AmnioLife Files U.S. Patent Application 10/31/2014
Cipla Ltd. Asks Government To Revoke Five Patents Held By Novartis AG (NVS) 10/30/2014
Levolta Pharmaceuticals Receives U.S. Patent For Novel Investigational Therapy For Controlling Osteoarthritis 10/30/2014
When Will Biosimilars Impact The U.S. Market? 10/30/2014